Evidence map›Paper›PMID 27556439›Full record

ArticleMolecules (Basel, Switzerland)2016

Curcumin Ameliorates Furazolidone-Induced DNA Damage and Apoptosis in Human Hepatocyte L02 Cells by Inhibiting ROS Production and Mitochondrial Pathway.

Chongshan Dai, Daowen Li, Lijing Gong, Xilong Xiao, Shusheng Tang

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
13.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 51 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Thyme Oil and Thymol Counter Doxorubicin-Induced HepatotoxicityOxidative medicine and cellular longevity · 2022
    Article
  10. Article
  11. Review
  12. Article
  13. Pharmaceutical biology · 2020
    Article
  14. Article
  15. Curcumin Protects Human Trophoblast HTR8/SVneo Cells from HAntioxidants (Basel, Switzerland) · 2020
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Chongshan DaiCollege of Veterinary Medicine, China Agricultural University, 2 Yuanmingyuan West Road, Beijing 100193, China. daichongshan@163.com.
Daowen LiCollege of Veterinary Medicine, China Agricultural University, 2 Yuanmingyuan West Road, Beijing 100193, China. lidaowen123.fff@163.com.
Lijing GongSport Science Research Center, Beijing Sport University, 48 Xinxi Road, Haidian District, Beijing 100084, China. argun@126.com.
Xilong XiaoCollege of Veterinary Medicine, China Agricultural University, 2 Yuanmingyuan West Road, Beijing 100193, China. xiaoxilong1958@163.com.
Shusheng TangCollege of Veterinary Medicine, China Agricultural University, 2 Yuanmingyuan West Road, Beijing 100193, China. tssfj@cau.edu.cn.
China Agricultural University · CNBeijing Sport University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Furazolidone (FZD), a synthetic nitrofuran derivative, has been widely used as an antibacterial and antiprotozoal agent. Recently, the potential toxicity of FZD has raised concerns, but its mechanism is still unclear. This study aimed to investigate the protective effect of curcumin on FZD-induced cytotoxicity and the underlying mechanism in human hepatocyte L02 cells. The results showed that curcumin pre-treatment significantly ameliorated FZD-induced oxidative stress, characterized by decreased reactive oxygen species (ROS) and malondialdehyde formation, and increased superoxide dismutase, catalase activities and glutathione contents. In addition, curcumin pre-treatment significantly ameliorated the loss of mitochondrial membrane potential, the activations of caspase-9 and -3, and apoptosis caused by FZD. Alkaline comet assay showed that curcumin markedly reduced FZD-induced DNA damage in a dose-dependent manner. Curcumin pre-treatment consistently and markedly down-regulated the mRNA expression levels of p53, Bax, caspase-9 and -3 and up-regulated the mRNA expression level of Bcl-2. Taken together, these results reveal that curcumin protects against FZD-induced DNA damage and apoptosis by inhibiting oxidative stress and mitochondrial pathway. Our study indicated that curcumin may be a promising combiner with FZD to reduce FZD-related toxicity in clinical applications.

Indexed as

AntioxidantsApoptosisCell LineCell SurvivalCurcuminDNA DamageFurazolidoneGene Expression RegulationGlutathioneHepatocytesHumansMembrane Potential, MitochondrialOxidative StressReactive Oxygen SpeciesSuperoxide DismutaseAntioxidantsCurcuminFurazolidoneGlutathioneReactive Oxygen SpeciesSuperoxide DismutasecurcuminDNA damagefurazolidonemitochondrial pathwayoxidative stress

Identifiers

PMID27556439
PMCPMC6272881
OpenAlexW2510821240

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.